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Clinical PerspectiveWhat Is New?This study demonstrates for the first time that microvascular vasomotor changes during mental stress in the digital circulation reflect changes in the coronary circulation.Microvascular endothelium‐dependent, but not ‐independent, function predicts coronary microvascular responses during mental stress in patients with coronary artery disease.What Are the Clinical Implications?Endothelial dysfunction results in impaired vasomotion during mental stress and thus contributes to development of mental stress--induced myocardial ischemia in patients with coronary artery disease.Whether improvement of endothelial function will improve coronary vascular responses to mental stress and reduce mental stress--induced myocardial ischemia needs further investigation.

 {#jah33169-sec-0008}

Mental stress (MS) has been linked to increased risk of cardiovascular diseases and adverse cardiovascular outcomes.[1](#jah33169-bib-0001){ref-type="ref"}, [2](#jah33169-bib-0002){ref-type="ref"}, [3](#jah33169-bib-0003){ref-type="ref"} Acute MS results in transient pathological hemodynamic and neuroendocrine activation.[4](#jah33169-bib-0004){ref-type="ref"} Vasomotor changes in the coronary conductance and resistance vessels modulate coronary blood flow (CBF) during physiologic and psychological stress.[5](#jah33169-bib-0005){ref-type="ref"}, [6](#jah33169-bib-0006){ref-type="ref"} For example, vasodilation of the epicardial and coronary microvasculature during maximal exercise can increase CBF by 4‐ to 5‐fold, with the greatest contribution coming from dilation of the resistance or microvessels.[7](#jah33169-bib-0007){ref-type="ref"} In the normal coronary circulation, acute MS results in dilation of both epicardial arteries and microvessels, increasing CBF to match the increase in demand imposed by the MS‐induced increases in blood pressure, heart rate, and contractility.[5](#jah33169-bib-0005){ref-type="ref"}, [8](#jah33169-bib-0008){ref-type="ref"}, [9](#jah33169-bib-0009){ref-type="ref"} In the presence of coronary artery disease (CAD), epicardial coronary arteries paradoxically constrict, and resistance vessel dilation is markedly impaired,[5](#jah33169-bib-0005){ref-type="ref"}, [10](#jah33169-bib-0010){ref-type="ref"} resulting in diminished vasodilation that, if severe enough, can lead to myocardial ischemia.[5](#jah33169-bib-0005){ref-type="ref"}, [8](#jah33169-bib-0008){ref-type="ref"}, [9](#jah33169-bib-0009){ref-type="ref"}, [10](#jah33169-bib-0010){ref-type="ref"}, [11](#jah33169-bib-0011){ref-type="ref"}, [12](#jah33169-bib-0012){ref-type="ref"} Other studies, however, have not confirmed this finding.[9](#jah33169-bib-0009){ref-type="ref"}, [12](#jah33169-bib-0012){ref-type="ref"}

The underlying mechanisms for these responses remain understudied. Coronary vasodilation is modulated by both endothelial and nonendothelial mechanisms. Vascular responses to endothelium‐dependent agonists such as acetylcholine estimate endothelial function and responses to endothelium‐independent agents including sodium nitroprusside reflect smooth muscle and other nonendothelial vasodilatory function; and responses to adenosine largely estimate maximal endothelium‐independent microvascular function or flow reserve. One study showed that the magnitude of coronary epicardial endothelial dysfunction significantly correlated with epicardial vasoconstriction during MS.[10](#jah33169-bib-0010){ref-type="ref"} To our knowledge, no study has assessed the relationship between the epicardial and microvascular responses to MS and coronary vascular endothelium‐dependent and ‐independent function, or with coronary flow reserve. A comprehensive assessment of these responses with MS was 1 goal of our investigation.

Several studies have assessed peripheral vascular changes by measuring digital vasoconstriction in response to MS, by utilizing a noninvasive peripheral arterial tonometry (PAT) device.[4](#jah33169-bib-0004){ref-type="ref"}, [13](#jah33169-bib-0013){ref-type="ref"}, [14](#jah33169-bib-0014){ref-type="ref"} The degree of peripheral microvascular constriction measured with this device has been related to the propensity toward MS‐induced myocardial ischemia (MSIMI) in patients with CAD.[4](#jah33169-bib-0004){ref-type="ref"}, [13](#jah33169-bib-0013){ref-type="ref"}, [14](#jah33169-bib-0014){ref-type="ref"} Whether there is any relationship between peripheral and coronary vasomotion during MS has not been previously studied and is a goal of our investigation.[4](#jah33169-bib-0004){ref-type="ref"}

In this study we aimed to examine the relationship between coronary vascular responses to MS and (1) endothelium‐dependent epicardial (coronary diameter response) and microvascular function (acetylcholine‐mediated CBF and resistance responses), (2) endothelium‐independent epicardial and microvascular function (sodium nitroprusside--mediated responses), and (3) endothelium‐independent coronary flow reserve (response to adenosine), in patients with stable CAD. We further examined the association between the peripheral and coronary vascular responses during MS. Our hypothesis was that MS‐induced coronary vascular responses are associated with endothelium‐dependent but not endothelium‐independent coronary epicardial and microvascular function. Second, we hypothesized that the coronary microcirculatory responses to MS will correlate with the digital peripheral microvascular reactivity.

Methods {#jah33169-sec-0009}
=======

The data, analytic methods, and study materials will not be made available to other researchers for purpose of reproducing the results or replicating the procedure.

Study Population {#jah33169-sec-0010}
----------------

Forty‐six people were enrolled from the Mental Stress Ischemia Prognosis Study,[15](#jah33169-bib-0015){ref-type="ref"} a prospective study that recruited patients with stable CAD between June 2011 and August 2014 at Emory University--affiliated hospitals. Presence of CAD was defined by an abnormal coronary angiogram demonstrating angiographic evidence of atherosclerosis with at least luminal irregularities. Patients with an acute coronary syndrome or with decompensated heart failure during the previous 2 months, end‐stage renal disease, or unstable psychiatric conditions were excluded. Clinical information including previous CAD events, CAD risk factors, coronary angiography results, and current medications were documented using standardized questionnaires and chart reviews. Patients were tested in the morning after a 12‐hour fast. Antianginal medications (β‐blockers, calcium‐channel blockers, and long‐acting nitrates), xanthine derivatives, and caffeine‐containing products were withheld for 24 hours before stress testing. Sedation was not given before catheterization in order to exclude the potential effects of these medications on reactivity during MS testing. The research protocol was approved by the Institutional Review Board, and all participants provided informed consent.

Cardiac Catheterization {#jah33169-sec-0011}
-----------------------

After insertion of a 7F femoral vascular sheath under local anesthesia and administration of 5000 U of heparin, routine coronary angiography was performed. Patients were not premedicated beforehand with analgesics or sedatives to avoid the effects of these medications on the responses to MS. All measurements were made in unobstructed coronary arteries (\<20% stenosis). A 0.014‐inch Doppler wire (Flowire, Volcano Corp, Rancho Cordova, CA) was advanced into a nondiseased segment of either the left anterior descending or the circumflex coronary artery through a 7F guide and a 3F infusion catheter and placed in a straight unoverlapped segment of the epicardial coronary artery without any side branches, which allowed measurement of a stable flow‐velocity signal.

Dextrose 5% was continuously infused through the infusion catheter at a rate of 1 mL/min. The coronary diameter for calculating CBF was measured in a segment 0.25 to 0.5 cm beyond the tip of the Doppler wire. CBF (mL/min) was estimated as π×average peak velocity (cm/s)×0.125×vessel diameter (mm). Coronary vascular resistance (CVR) was calculated as mean arterial pressure÷CBF. To measure epicardial changes during the drug infusions and MS, coronary diameter was also measured in a long (\>1 cm) distal segment of the study coronary artery where the effects of the infused drugs would be evident. Coronary artery diameter changes were measured off‐line in the Emory cardiovascular imaging and biomechanical core laboratory using a computerized edge‐detection system (PIE Medical Imaging, Maastricht, The Netherlands) by investigators blinded to the patients' demographic and clinical data.[16](#jah33169-bib-0016){ref-type="ref"} Rate‐pressure product was calculated as mean arterial blood pressure×heart rate.

Study Protocol {#jah33169-sec-0012}
--------------

After completion of the diagnostic coronary angiogram and placement of the Doppler Flowire, there was a 10‐minute resting period before measurement of resting blood pressure, heart rate, and average peak velocity and performance of a coronary angiogram (Figure [1](#jah33169-fig-0001){ref-type="fig"}, Figures [S1](#jah33169-sup-0001){ref-type="supplementary-material"} and [S2](#jah33169-sup-0001){ref-type="supplementary-material"}). This was followed by measurement of endothelium‐dependent vasodilation during infusion of intracoronary acetylcholine at a rate of 15 μg/min for 3 minutes to obtain an estimated 10^−6^ mol/L intracoronary concentration (n=36). After a 5‐ to 10‐minute period to allow for equilibration, coronary flow reserve was measured after a 2‐minute infusion of intracoronary adenosine at 2.2 mg/min (n=31). After a 15‐minute period to allow for equilibration, patients underwent mental arithmetic stress testing (n=38). At the end of 5 minutes of MS testing, the aforementioned measurements were repeated. Fifteen minutes after completion of the MS test, endothelium‐dependent vasodilation was remeasured with repeat infusion of intracoronary acetylcholine followed by measurement of endothelium‐independent function after infusion of sodium nitroprusside at 20 μg/min for 3 minutes (n=24). Coronary flow and diameter measurements were repeated at the end of each intervention.

![Schematic flowchart of the study protocol and respective measurements. APV indicates average peak velocity; BP, blood pressure; HR, heart rate; MS, mental stress test; PAT, peripheral arterial tonometry.](JAH3-7-e008532-g001){#jah33169-fig-0001}

Digital Blood Flow Measurement Using Finger Plethysmography {#jah33169-sec-0013}
-----------------------------------------------------------

During the aforementioned study, digital pulse wave amplitude was continuously measured at rest and during MS using PAT (Itamar Medical, Caesarea, Israel) as previously described.[13](#jah33169-bib-0013){ref-type="ref"}, [14](#jah33169-bib-0014){ref-type="ref"} Analyzable data free of artifact were available in 24 patients. Briefly, the device, which uses a modified form of plethysmography, was applied to the index finger on the side opposite to the operator. Registered pressure changes were fed into a personal computer where the signal was filtered, amplified, stored, and analyzed in an operator‐independent manner. The baseline pulse wave amplitude was determined by averaging the last 3 minutes of recording that preceded MS testing. The amplitude during MS was determined as the lowest pulse wave amplitude during the arithmetic test. The PAT ratio was calculated as the ratio of the minimum pulse wave amplitude during MS to the baseline, with a ratio \<1 signifying a vasoconstrictive response.[4](#jah33169-bib-0004){ref-type="ref"}

Statistical Analysis {#jah33169-sec-0014}
--------------------

Baseline data are reported as mean±SD, median (interquartile range), or percentage. Linear regression with repeated measures was employed to test the change in coronary epicardial diameter, CBF, and CVR with each intervention. The median percentage changes are reported with 95% confidence intervals, which were computed based on order statistics using an incomplete β distribution. The Spearman rank correlation was utilized to test associations between the responses during MS and during coronary and peripheral vascular testing. Patients were grouped based on their CBF responses to acetylcholine and nitroprusside using median cutoff values and using a cutoff of 2.5 for coronary flow reserve.[17](#jah33169-bib-0017){ref-type="ref"} The Mann‐Whitney U test was used to test differences between groups in response to MS. Statistical analyses were conducted using SPSS (v 23.0, IBM Corp, Armonk, NY).

Results {#jah33169-sec-0015}
=======

Of the 46 enrolled subjects, 8 patients could not complete the study either for symptomatic reasons or because the CAD was not suitable for insertion of the Flowire and administration of acetylcholine. Thus, 38 subjects, mean age 59±8 years, were included in the analysis (Table [1](#jah33169-tbl-0001){ref-type="table"}).

###### 

Patient Characteristics

                                              Mean (SD), Median \[IQR\], or %
  ------------------------------------------- ---------------------------------
  Clinical variables                          
  Number                                      38
  Age, y                                      59±8
  Male, %                                     84
  Black, %                                    49
  Body mass index, kg/m^2^                    30±7
  Diabetes mellitus, %                        30
  Hypertension, %                             71
  Hyperlipidemia, %                           81
  Ever smoking, %                             68
  Myocardial infarction, %                    14
  Ejection fraction, %                        57±10
  Previous history                            
  Percutaneous coronary intervention, %       19
  Heart failure, %                            13
  Depression, %                               19
  PTSD, %                                     5
  Medications                                 
  Aspirin, %                                  65
  Clopidogrel, %                              16
  Statins, %                                  61
  β‐Blockers, %                               45
  ACE inhibitors, %                           30
  Resting hemodynamics                        
  Heart rate, bpm                             77±12
  Mean arterial blood pressure, mm Hg         112±15
  RPP, mm Hg·bpm                              7568±1892
  Cardiac catheterization results             
  Primary diagnosis of diagnostic angiogram   
  Obstructive CAD, %                          26
  Nonobstructive CAD, %                       71
  Vasospastic angina, %                       3
  Gensini score                               7.0 \[2.5, 15.5\]
  Percentage stenosis of the study vessel     10% \[10%, 20%\]

ACE indicates angiotensin‐converting enzyme; bpm, beats per minute; CAD, coronary artery disease; IQR, interquartile range; PTSD, posttraumatic stress disorder; RPP, rate‐pressure product.

Coronary Vascular Responses During MS {#jah33169-sec-0016}
-------------------------------------

MS testing, performed after 15 minutes of equilibration following preceding intracoronary vasomotor challenges, resulted in a significant increase in heart rate (mean±SD) (18±17 beats/min), mean arterial pressure (14±11 mm Hg), and rate‐pressure product (22%±23%), *P*\<0.001 for all (Figure [2](#jah33169-fig-0002){ref-type="fig"}, Table [S1](#jah33169-sup-0001){ref-type="supplementary-material"}). Overall, there was significant epicardial coronary arterial constriction (median interquartile range −5.9% \[−10.5, −2.6\]; *P*=0.001) during MS, but the responses were heterogeneous; 8 patients had epicardial vasodilation, whereas 30 had constriction during MS (Figure [2](#jah33169-fig-0002){ref-type="fig"}, Table [S1](#jah33169-sup-0001){ref-type="supplementary-material"}, Figure [S3](#jah33169-sup-0001){ref-type="supplementary-material"}). Overall, there was no change in the CBF −2.6% (−13.3%, 15.7%) or CVR 12.0% (−9.0%, 18.6%), but the responses were heterogeneous (Figure [2](#jah33169-fig-0002){ref-type="fig"}, Table [S1](#jah33169-sup-0001){ref-type="supplementary-material"}, Figure [S3](#jah33169-sup-0001){ref-type="supplementary-material"}).

![Hemodynamic and coronary vascular responses during mental stress (MS). Bars and error bars represent the median change and 95% confidence interval, respectively. CBF indicates coronary blood flow; CI, confidence interval; CVR, coronary vascular resistance; HR, heart rate; MAP, mean arterial pressure.](JAH3-7-e008532-g002){#jah33169-fig-0002}

Endothelium‐Dependent Function and Response to MS {#jah33169-sec-0017}
-------------------------------------------------

Acetylcholine (10^−6^ mol/L) infusion, performed after the baseline measurements and before any other pharmacologic testing, caused a significant increase in CBF (38.5% \[8.1%, 91.3%\], *P*=0.001) and decrease in CVR (−29.1% \[−49.0%, −3.4%\], *P*=0.001), but no overall change in coronary epicardial diameter (0.1% \[−10.9%, 8.2%\], *P*=not significant) (Table [S1](#jah33169-sup-0001){ref-type="supplementary-material"}). The responses were heterogeneous (Figures [S4](#jah33169-sup-0001){ref-type="supplementary-material"}A and [S5](#jah33169-sup-0001){ref-type="supplementary-material"}A).

There was a significant correlation between the microvascular vasodilator responses, measured as changes in CBF during MS and the CBF changes with the endothelium‐dependent dilator acetylcholine (*r*=0.38, *P*=0.03) (Figure [3](#jah33169-fig-0003){ref-type="fig"}A). The correlation between coronary epicardial diameter changes during MS and during acetylcholine infusion was not significant (*r*=0.15, *P*=0.40) (Figure [3](#jah33169-fig-0003){ref-type="fig"}B). However, all patients who had vasoconstriction in response to acetylcholine had vasoconstriction during MS, whereas the response in those who dilated during acetylcholine infusion was more heterogeneous (Figure [3](#jah33169-fig-0003){ref-type="fig"}B). Last, the correlation between the CVR changes during MS and with acetylcholine did not reach statistical significance (*r*=0.26, *P*=0.17).

![Relationship between coronary blood flow (CBF) and epicardial responses during mental stress (MS) and acetylcholine infusion. *r* values are Spearman correlation coefficients. A, The solid line represents the line of best fit, and the dashed lines represent 95% confidence interval. B, The vertical and the horizontal reference lines (dashed) represent no change in epicardial diameter in response to acetylcholine and MS, respectively.](JAH3-7-e008532-g003){#jah33169-fig-0003}

We grouped patients based on their coronary microvascular responses to acetylcholine using a median cutoff of CBF response into those with "less healthy" endothelial function (\<median response) and those with "healthier" endothelium (≥median response). In patients with \<median CBF response to acetylcholine, the respective responses during MS were significantly lower than those in subjects with healthier endothelial function (\>median response to acetylcholine) (Figure [4](#jah33169-fig-0004){ref-type="fig"}A). However, there were no differences between the epicardial responses to acetylcholine and the epicardial responses to MS.

![Relationship between coronary microvascular responses during mental stress and during (A) acetylcholine, (B) sodium nitroprusside, and (C) adenosine infusions. Subjects divided by median CBF responses. Bars and error bars represent the median change and 95% CI, respectively. CBF indicates coronary blood flow; CI, confidence interval; CVR, coronary vascular resistance.](JAH3-7-e008532-g004){#jah33169-fig-0004}

We also compared the coronary vascular responses to acetylcholine in 20 subjects before and 15 minutes after MS. There were no differences between the epicardial and microvascular responses before and after MS testing; post‐MS, CBF +45.3% (16.7%, 150.4%), CVR −34.9% (−56.6%, −15.1%), and epicardial coronary changes +1.4% (−7.4%, 7.6%) were similar to pre‐MS testing values (Table [S1](#jah33169-sup-0001){ref-type="supplementary-material"}).

Endothelium‐Independent Function and Response to MS {#jah33169-sec-0018}
---------------------------------------------------

Sodium nitroprusside administration, following post‐MS acetylcholine challenge, dilated the coronary epicardial arteries (11.9% \[7.8%, 22.3%\], *P*\<0.001) and microcirculation (CBF increased 97.3% \[58.2%, 147.4%\] and CVR decreased −55.1% \[−67.2%, −47.7%\], both *P*\<0.001) (Table [S1](#jah33169-sup-0001){ref-type="supplementary-material"}, Figures [S4](#jah33169-sup-0001){ref-type="supplementary-material"}B and [S5](#jah33169-sup-0001){ref-type="supplementary-material"}B). There was no correlation between the coronary flow or diameter responses to nitroprusside and the responses to MS (Spearman rank correlation of 0.07, *P*=0.74). We then grouped patients based on their microvascular response to nitroprusside into those with high versus low response using a median cutoff. There was also no significant difference in MS‐induced change in CBF or CVR between those with high response versus low response to sodium nitroprusside, respectively (Figure [4](#jah33169-fig-0004){ref-type="fig"}B).

Coronary Flow Reserve and Response to MS {#jah33169-sec-0019}
----------------------------------------

Intracoronary adenosine, infused after the acetylcholine challenge, significantly increased CBF (244% \[166%, 398%\]) and decreased CVR (−71.6% \[−79.1%, −58.8%\]), *P*\<0.001 for both (Table [S1](#jah33169-sup-0001){ref-type="supplementary-material"}, Figures [S4](#jah33169-sup-0001){ref-type="supplementary-material"}C and [S5](#jah33169-sup-0001){ref-type="supplementary-material"}C). There was no statistically significant correlation between the changes in CBF and CVR with adenosine and MS‐induced vasodilation (*r*=−0.10, *P*=0.6). In the 16 patients with normal coronary flow reserve \>2.5 compared to 15 with coronary flow reserve \<2.5, there was no difference in the coronary vasomotor responses during MS, (Figure [4](#jah33169-fig-0004){ref-type="fig"}C).

Relationship Between Coronary and Peripheral Responses to MS {#jah33169-sec-0020}
------------------------------------------------------------

MS testing resulted in significant peripheral vasoconstriction; the PAT ratio was 0.76±0.17 (\<1 indicates digital microvascular constriction). There was a strong inverse correlation (*r*=−0.60, *P*=0.004) between the PAT ratio and the demand‐adjusted coronary microvascular vasodilation, measured as the ratio of rate‐pressure product to CBF (Table [2](#jah33169-tbl-0002){ref-type="table"}). Thus, subjects with reduced demand‐adjusted coronary vasodilation during MS also had reduced peripheral digital microvascular vasodilation (PAT ratio), and vice versa (Figure [5](#jah33169-fig-0005){ref-type="fig"}). No significant correlations were observed between the PAT ratio during MS and MS‐induced changes in the coronary epicardial diameter, CBF, or CVR (Table [2](#jah33169-tbl-0002){ref-type="table"}).

###### 

Relationship Between Peripheral Microvascular Responses During MS Measured as the PAT Ratio and Coronary Vasomotor Responses During MS

  Change With Mental Stress   Spearman Rank Correlation   *P* Value
  --------------------------- --------------------------- ----------------------------------------------
  Epicardial diameter         0.28                        0.18
  CBF                         0.29                        0.20
  CVR                         −0.36                       0.11
  RPP/CBF                     −0.60                       0.004[a](#jah33169-note-0004){ref-type="fn"}

CBF indicates coronary blood flow; CVR, coronary vascular resistance; MS, mental stress; PAT, peripheral arterial tonometry; RPP, rate pressure response.

Statistically significant P‐value.

![Relationship between mental stress--induced digital microvascular response, measured as the peripheral arterial tonometry (PAT) ratio, and the coronary microvascular vasomotor response, measured as the coronary blood flow (CBF) response adjusted for the rate‐pressure product (RPP). The solid line represents the line of best fit, and the dashed lines represent the 95% confidence interval.](JAH3-7-e008532-g005){#jah33169-fig-0005}

Discussion {#jah33169-sec-0021}
==========

Our findings demonstrate that in patients with CAD, there is a significant relationship between coronary *microvascular* responses to MS, measured as changes in CBF and CVR, and the underlying coronary *microvascular* endothelium‐dependent, but not endothelium‐independent function. Thus, patients with worse coronary microvascular endothelial function had reduced microvascular vasodilation in response to MS, whereas those with more preserved endothelial function had greater vasodilation with MS. However, we did not observe a clear relationship between coronary epicardial endothelial function and the epicardial responses to MS.

Second, there was a strong relationship between the magnitude of coronary microvascular vasodilation, adjusted for myocardial oxygen demand, and the digital peripheral microvascular response during MS, suggesting that similar factors influence coronary and peripheral microvascular reactivity during stress. Taken together, our study shows, for the first time that the health of the coronary microvascular endothelium, at least partly determines coronary vasodilation during psychological stress, and the latter is reflected in the peripheral microvascular vasomotor responses during MS. These findings illustrate potential mechanisms in the pathogenesis of MSIMI that occurs frequently in patients with CAD and is associated with poor outcomes.[1](#jah33169-bib-0001){ref-type="ref"}, [2](#jah33169-bib-0002){ref-type="ref"}, [18](#jah33169-bib-0018){ref-type="ref"}, [19](#jah33169-bib-0019){ref-type="ref"} We have previously shown that lower digital microvascular reactivity is associated with MSIMI.[4](#jah33169-bib-0004){ref-type="ref"}, [13](#jah33169-bib-0013){ref-type="ref"}, [14](#jah33169-bib-0014){ref-type="ref"} In conclusion, this study shows that the health of the endothelium, but not the endothelium‐independent pathways, modulates coronary and peripheral microvascular reactivity, and therefore blood flow delivery during MS.

We and others have previously shown that epicardial segments of coronary arteries in individuals free of atherosclerosis tend to vasodilate during MS, but in those with CAD, even angiographically smooth segments do not vasodilate, whereas segments with angiographic atherosclerosis tend to vasoconstrict.[5](#jah33169-bib-0005){ref-type="ref"}, [9](#jah33169-bib-0009){ref-type="ref"}, [10](#jah33169-bib-0010){ref-type="ref"}, [11](#jah33169-bib-0011){ref-type="ref"} Kop et al further showed that nonstenotic atherosclerotic segments vasoconstrict but not segments with significant atherosclerosis.[9](#jah33169-bib-0009){ref-type="ref"} Two studies that investigated the relationship between coronary epicardial responses during MS and endothelial function showed that segments with epicardial atherosclerosis vasoconstrict, whereas segments without atherosclerosis vasodilate in response to both MS and acetylcholine.[10](#jah33169-bib-0010){ref-type="ref"}, [11](#jah33169-bib-0011){ref-type="ref"} In contrast to these studies we investigated a homogenous population *with* CAD in whom changes in epicardial arteries without significant (\<20%) stenosis were studied. Although we found no significant correlation between epicardial responses to MS and acetylcholine, all epicardial segments that constricted with acetylcholine also constricted during MS, whereas the response in those without acetylcholine‐mediated constriction was more heterogeneous. It should be emphasized that we selected a single straight unobstructed epicardial segment for measurement in each subject. It is possible that more diseased segments may have shown results similar to those previously reported. Furthermore, with a larger sample size, the correlation could have reached statistical significance.

We and others have previously shown that MS causes greater microvascular vasodilation and thus increase in CBF in those without CAD compared to those with CAD, even with similar increases in rate‐pressure product and thus myocardial oxygen demand.[5](#jah33169-bib-0005){ref-type="ref"}, [9](#jah33169-bib-0009){ref-type="ref"} We further showed that despite similar activation of the sympathetic nervous system, measured as coronary norepinephrine turnover with acute MS, patients with CAD had impaired coronary microvascular vasodilation compared to those without CAD.[5](#jah33169-bib-0005){ref-type="ref"} Thus, MS‐induced sympathetic nervous system activation increases myocardial oxygen demand and stimulates α‐adrenergic receptor‐mediated coronary constriction. In the presence of normal vascular endothelial function, this vasoconstriction is countered by shear‐mediated release of nitric oxide and other endothelium‐dependent vasodilators. With endothelial dysfunction, the adrenergic receptor‐mediated constriction supervenes, and the resulting coronary vasoconstriction limits appropriate CBF increase, potentially resulting in MSIMI. A novel finding of this study is demonstration of the critical relationship between coronary *microvascular* endothelial function and the vasodilatory response to MS. Regardless of the underlying atherosclerosis burden, endothelial function, and not endothelium‐independent responses, modulates the coronary microvascular dilator response to MS.

Endothelial dysfunction is a precursor for the development and progression of CAD, and both epicardial and microvascular responses to acetylcholine are predictive of future risk of adverse cardiovascular outcomes.[20](#jah33169-bib-0020){ref-type="ref"}, [21](#jah33169-bib-0021){ref-type="ref"} An impaired response to acetylcholine is indicative of reduced endothelial production of nitric oxide and/or other endothelium‐dependent vasodilators such as endothelium‐dependent hyperpolarizing factor.[22](#jah33169-bib-0022){ref-type="ref"}, [23](#jah33169-bib-0023){ref-type="ref"} Our current findings demonstrating the contribution of coronary endothelial dysfunction to the reduced microvascular dilation during MS, combined with the observation that MSIMI occurs in some patients with CAD, illustrate that 1 likely mechanism by which endothelial dysfunction contributes to increased cardiovascular risk is by promoting MSIMI.

Another important finding of our study is the similarity in the coronary and peripheral microvascular vasomotor responses during MS, demonstrated as a strong correlation between the digital microvascular vasomotion during MS, measured as the PAT ratio and coronary microvascular vasodilation, measured as demand‐adjusted change in CBF. Combined with the previous observation that the PAT ratio during MS is an important and independent predictor of MSIMI,[13](#jah33169-bib-0013){ref-type="ref"}, [24](#jah33169-bib-0024){ref-type="ref"}, [25](#jah33169-bib-0025){ref-type="ref"} our current findings imply that microvascular endothelial function is likely to be a critical determinant of MSIMI and that the digital microvascular reactivity reflects coronary microvascular reactivity during stress. Previous studies have shown that forearm microvascular vasodilation during mental stress is impaired in subjects with abnormal endothelial function, lower nitric oxide bioactivity, and greater endothelin activity.[26](#jah33169-bib-0026){ref-type="ref"}, [27](#jah33169-bib-0027){ref-type="ref"}, [28](#jah33169-bib-0028){ref-type="ref"}, [29](#jah33169-bib-0029){ref-type="ref"}, [30](#jah33169-bib-0030){ref-type="ref"}

Strength and Limitations {#jah33169-sec-0022}
------------------------

This is the first study to demonstrate the relationship between microvascular endothelial dysfunction and coronary microvascular responses during MS in patients with CAD, and to further demonstrate the similarity between peripheral and coronary microvascular reactivity with stress. Limitations include the lack of information on MSIMI in this cohort. Further studies comparing coronary endothelial function between those with and without MSIMI are needed. Because of the small number of subjects in the study, lack of statistical significance with some tests may have been due to lack of statistical power, and the examination of subgroup differences according to sex and other comorbidities was limited. A larger study would be needed to make such comparisons. It should also be emphasized that the correlation between endothelial dysfunction and MS‐induced vasomotion does not imply causality. Studies designed to improve endothelial function and its impact on coronary and peripheral vasomotor responses during MS are needed to establish causality.

Conclusions and Implications {#jah33169-sec-0023}
============================

MSIMI is associated with increased risk of adverse cardiovascular outcomes, but its underlying mechanisms are not well understood.[18](#jah33169-bib-0018){ref-type="ref"} Herein we demonstrate the important contribution of coronary microvascular endothelial dysfunction to the limitation in vasodilation during MS in patients with CAD. Moreover, we demonstrate that coronary and peripheral microvascular responses during MS are similar. Whether improvement of endothelial dysfunction with angiotensin antagonists, statins, and other agents will improve coronary and peripheral responses to MS and improve MSIMI needs to be examined.
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**Table S1.** Hemodynamic and Intracoronary Doppler Measurements During the Individual Steps of the Study Protocol

**Figure S1.** Intracoronary Doppler tracing and respective hemodynamic measurements of a subject during the study protocol. Baseline (A) was the reference for acetylcholine (B) and adenosine (C). Pre‐MS (D) was the reference for MS (E), and post‐MS (F) was the reference for nitroprusside (G). APV indicates average peak velocity; BPM, beats per minute; CBF, coronary blood flow; CVR, coronary vascular resistance; HR, heart rate; MAP, mean arterial pressure; MS, mental stress test; Ref, reference.

**Figure S2.** Illustrative example of coronary angiography of a subject during the study protocol. Left anterior descending artery was studied for this subject. MS indicates mental stress test.

**Figure S3.** Coronary vascular responses to mental stress. Each line represents 1 patient. CBF indicates coronary blood flow; CVR, coronary vascular resistance.

**Figure S4.** Coronary epicardial and microvascular responses to acetylcholine, nitroprusside, and adenosine. Data are expressed as percentage change. Bars represent median change, and error bars represent 95% confidence interval.

**Figure S5.** Coronary vascular responses to acetylcholine, nitroprusside, and adenosine. Each line represents 1 patient. CBF indicates coronary blood flow; CVR, coronary vascular resistance.
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Click here for additional data file.
